BRIEF published on 02/12/2026 at 14:35, 8 months 24 days ago NanoViricides dépose une demande de désignation de médicament orphelin pour le NV-387 dans le traitement de la MPox. NanoViricides NV-387 Désignation De Médicament Orphelin Demande Auprès De La FDA Traitement MPox
PRESS RELEASE published on 02/12/2026 at 14:30, 8 months 24 days ago MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides NanoViricides files Orphan Drug Designation application with US FDA for NV-387 as treatment for MPox, a contagious disease with potential global pandemic threat NanoViricides NV-387 Orphan Drug Designation Mpox US FDA
BRIEF published on 02/10/2026 at 14:35, 8 months 26 days ago NanoViricides Pursues Orphan Drug Designation for Measles Treatment NanoViricides NV-387 FDA Approval Orphan Drug Designation Measles Treatment
BRIEF published on 02/10/2026 at 14:35, 8 months 26 days ago NanoViricides sollicite la désignation de médicament orphelin pour le traitement de la rougeole NanoViricides NV-387 Désignation De Médicament Orphelin Approbation De La FDA Traitement De La Rougeole
PRESS RELEASE published on 02/10/2026 at 14:30, 8 months 26 days ago Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides NanoViricides files for Orphan Drug Designation for NV-387 as Measles treatment with potential FDA incentives. Strong in vivo activity against Measles shown in humanized animal model study NanoViricides NV-387 Orphan Drug Designation Measles Treatment FDA Incentives
BRIEF published on 02/02/2026 at 14:35, 9 months 6 days ago NanoViricides présente des avancées antivirales avec le NV-387 NanoViricides NV-387 Essais Cliniques À Large Spectre Thérapie Antivirale
BRIEF published on 02/02/2026 at 14:35, 9 months 6 days ago NanoViricides Showcases Antiviral Advancements with NV-387 NanoViricides NV-387 Clinical Trials Antiviral Therapy Broad-spectrum
PRESS RELEASE published on 02/02/2026 at 14:30, 9 months 6 days ago NanoViricides President Dr. Diwan Interviewed by Mission Matters' Adam Torres NanoViricides, Inc. announces President Dr. Anil R. Diwan's interview on Mission Matters Podcast discussing revolutionary antiviral drugs development and NV-387 efficacy against various viruses NV-387 Antiviral Drugs NanoViricides Inc. Dr. Anil R. Diwan Mission Matters Podcast
BRIEF published on 01/13/2026 at 14:35, 9 months 26 days ago NanoViricides souligne le besoin d'antiviraux à large spectre face à la recrudescence de la grippe NV-387 Infections Respiratoires Antiviraux À Large Spectre Virus De La Grippe Résistance Antivirale
BRIEF published on 01/13/2026 at 14:35, 9 months 26 days ago NanoViricides Highlights Need for Broad-Spectrum Antivirals Amid Influenza Surge NV-387 Respiratory Infections Broad-spectrum Antivirals Influenza Virus Antiviral Resistance
Published on 11/06/2026 at 22:15, 2 days 5 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 14 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 14 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 14 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 01:55, 1 hour 33 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 15 hours 17 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 17 hours 12 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 13 hours ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 7 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:06, 2 days 8 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 2 days 8 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 2 days 8 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 2 days 8 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
